$34.4
Currently 17 wall-street analysts regularly analyze the financials of Viking Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Viking Therapeutics, Inc. (VKTX) have a share price target of $92.76. This median of share price forecast represents a 169.66% upside from the latest price of $34.4 as on 26.10.25.
As per the chart shown above, analysts believe that the Viking Therapeutics, Inc. (VKTX) share price will touch around $92.76 in next 12-months.
Below is a chart showing the percentage difference between Viking Therapeutics, Inc.'s share price and its median forecast price. As on 26.10.25, the difference is -70.5%
Based on 17 analysts tracking and researching Viking Therapeutics, Inc. (VKTX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 8 | 8 | 8 |
| Outperform | 7 | 8 | 8 |
| Hold | 1 | 1 | 1 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |